Oncology News

Datopotamab deruxtecan significantly improved PFS compared with chemotherapy in patients with previously treated inoperable or metastatic hormone receptor-positive, HER2-negative breast cancer, according to the agent’s manufacturers.

Researchers from City of Hope have detailed results of preclinical studies designed to optimize the durability of chimeric antigen receptor T cells for advanced ovarian cancer.

Patients with metastatic breast cancer treated with alpelisib as standard care had elevated blood glucose levels compared with those who received the drug as part of a clinical trial, according to data published in Cancer.

Breast cancer accounts for nearly one-third of new cancer diagnoses among women in the United States.

  Healio spoke to Emma Rossi, MD, gynecological oncologist at Duke Cancer Center, about combining different therapeutic modalities for advanced endometrial cancer.

  Healio spoke to Emma Rossi, MD, gynecological oncologist at Duke Cancer Center, about current and emerging prognostic biomarkers of endometrial cancer.

  Healio spoke to Emma Rossi, MD, gynecological oncologist at Duke Cancer Center, about treatment options for advanced recurrent endometrial cancer.

  Healio spoke to Emma Rossi, MD, gynecological oncologist at Duke Cancer Center, about recent advancements in endometrial cancer.

When all eligible patients were automatically referred for breast cancer screening, mammography completion did not improve, but staff burden worsened, according to the results of research published in JAMA Internal Medicine.

Because ovarian cancer is one of the more difficult cancers to diagnose, it is important for health care providers and women to understand how symptoms present, how to mitigate risk and how to prevent disease progression.